Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C16H24N2 · HCl
CAS Number:
Molecular Weight:
280.84
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
214-936-4
MDL number:
Quality level:
Quality Level
originator
Novartis
SMILES string
CC1=CC(C(C)(C)C)=CC(C)=C1CC2=NCCN2.Cl
InChI
1S/C16H24N2.ClH/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15;/h8-9H,6-7,10H2,1-5H3,(H,17,18);1H
InChI key
YGWFCQYETHJKNX-UHFFFAOYSA-N
Gene Information
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
Biochem/physiol Actions
α-adrenoceptor agonist; imidazoline binding site ligand.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Still not finding the right product?
Explore all of our products under Xylometazoline hydrochloride
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Catherine E Rennie et al.
International forum of allergy & rhinology, 1(2), 128-135 (2012-01-31)
This study quantifies the time-varying flow rate during inspiration at rest and in sniffing, both predecongestion and postdecongestion. It aims to provide a better understanding of nasal airflow mechanics, for application to the physiological modeling of nasal respiration and to
Jacek Sein Anand et al.
Przeglad lekarski, 66(6), 290-292 (2009-10-01)
The aim of our study was to present cases of misuse of different substances theoretically without abuse potential. In the last few years such behavior became an increasing problem in toxicological and emergency units. Lack of typical signs of intoxication
Katarzyna Korzeniowska et al.
Przeglad lekarski, 69(10), 1168-1169 (2013-02-21)
The article describes the case of 34-years old man, who has used nasal drops with xylomethazoline for three years. Health consequence of uncontrolled use of the drops and treatment were prescribed. Described problem confirms the need of physicians and pharmacists
